UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000029259
Receipt number R000033438
Scientific Title Reconstruction of splenic vein after pancreaticoduodenectomy with splenic vein ligation: prospective study
Date of disclosure of the study information 2017/10/01
Last modified on 2023/03/30 09:34:34

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Reconstruction of splenic vein after pancreaticoduodenectomy with splenic vein ligation: prospective study

Acronym

Reconstruction of splenic vein after pancreaticoduodenectomy

Scientific Title

Reconstruction of splenic vein after pancreaticoduodenectomy with splenic vein ligation: prospective study

Scientific Title:Acronym

Reconstruction of splenic vein after pancreaticoduodenectomy

Region

Japan


Condition

Condition

resectable or borderline resectable pancreatic cancer

Classification by specialty

Hepato-biliary-pancreatic surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To examine the efficacy of splenic vein reconstruction after pancreaticoduodenectomy with splenic vein ligation to prevent bleeding from varices that are sometimes made after this operation.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The patency of reconstructed splenic vein, the development of varices and splenic hypertrophy rate.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

Reconstruction of splenic vein after pancreaticoduodenectomy with splenic vein resection.

Interventions/Control_2

No reconstruction of splenic vein after pancreaticoduodenectomy with splenic vein resection.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

1) Patients who undergo pancreaticoduodenectomy with splenic vein resection regardless of neoadjuvant chemo(radiation) therapy.
2) Performance status should be 0-1.
3) Patients who understand the explanation of this study.

Key exclusion criteria

1) Patients who has collaterals due to portal vein obstruction before surgery.
2) Patients who was considered inappropriate by doctors.

Target sample size

50


Research contact person

Name of lead principal investigator

1st name Yu
Middle name
Last name Takahashi

Organization

The Cancer Institute Hospital Of JFCR

Division name

Department of Gastroenterological Surgery

Zip code

135-8550

Address

3-8-31 Ariake, Kotoku, Tokyo, Japan

TEL

03-3520-0111

Email

yu.takahashi@jfcr.or.jp


Public contact

Name of contact person

1st name Yoshihiro
Middle name
Last name Ono

Organization

The Cancer Institute Hospital Of JFCR

Division name

Department of Gastroenterological Surgery

Zip code

135-8550

Address

3-8-31 Ariake, Kotoku, Tokyo, Japan

TEL

03-3520-0111

Homepage URL


Email

yoshihiro.ono@jfcr.or.jp


Sponsor or person

Institute

The Cancer Institute Hospital Of JFCR

Institute

Department

Personal name



Funding Source

Organization

The Cancer Institute Hospital Of JFCR

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

The Cancer Institute Hospital Of JFCR

Address

3-8-31 Ariake, Kotoku, Tokyo, Japan

Tel

03-3520-0111

Email

yoshihiro.ono@jfcr.or.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

がん研有明病院


Other administrative information

Date of disclosure of the study information

2017 Year 10 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2017 Year 05 Month 15 Day

Date of IRB

2017 Year 10 Month 03 Day

Anticipated trial start date

2017 Year 10 Month 03 Day

Last follow-up date

2023 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2017 Year 09 Month 23 Day

Last modified on

2023 Year 03 Month 30 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000033438


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name